Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.98 USD | -17.31% | -18.26% | -41.33% |
08:41pm | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
07:29pm | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- CYTK Stock
- Revisions Cytokinetics, Incorporated